Holen Sie sich die Stockscreener-App
15.96
1.40%
0.22
Schlusskurs vom Vortag:
$15.74
Offen:
$15.81
24-Stunden-Volumen:
881.86K
Relative Volume:
1.06
Marktkapitalisierung:
$1.35B
Einnahmen:
$17.49M
Nettoeinkommen (Verlust:
$-78.50M
KGV:
-13.30
EPS:
-1.2
Netto-Cashflow:
$-52.85M
1W Leistung:
+10.76%
1M Leistung:
+31.03%
6M Leistung:
+44.30%
1J Leistung:
+17.87%
1-Tages-Spanne:
$15.52
$16.18
1-Wochen-Bereich:
$13.89
$16.18
52-Wochen-Spanne:
$8.26
$16.99
Liquidia Corp Stock (LQDA) Company Profile
Firmenname
Liquidia Corp
Sektor
Branche
Telefon
919.328.4400
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Vergleichen Sie LQDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
15.96 | 1.35B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
481.16 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.07 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
657.97 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
278.25 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
119.94 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Eingeleitet | Raymond James | Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Perform |
| 2024-01-05 | Bestätigt | Needham | Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Underperform |
| 2022-09-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2022-07-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-05-31 | Eingeleitet | BTIG Research | Buy |
| 2022-05-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-09-05 | Eingeleitet | Wedbush | Outperform |
| 2018-08-20 | Eingeleitet | Jefferies | Buy |
| 2018-08-20 | Eingeleitet | Needham | Buy |
Alle ansehen
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
Stock Performance Spotlight: Liquidia Corp (LQDA) Ends the Day at 15.74, Up by 3.89 - The Dwinnex
Liquidia Corp.: We Have Exposure To The Upside Now - Seeking Alpha
Liquidia Corp (LQDA) stock on the rise: An overview - US Post News
Liquidia Co. (NASDAQ:LQDA) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
This trade activity should not be overlooked: Liquidia Corp (LQDA) - SETE News
Liquidia Corp [LQDA] Investment Appeal on the Rise - Knox Daily
Liquidia Corporation's Long-Running Saga Is Coming To An End (NASDAQ:LQDA) - Seeking Alpha
Liquidia Corp's chief business officer sells $6,319 in stock - MSN
Liquidia Corp's chief medical officer sells $31,785 in stock - MSN
Liquidia Co. (NASDAQ:LQDA) Insider Sells $31,785.00 in Stock - MarketBeat
Liquidia Corp's chief medical officer sells $31,785 in stock By Investing.com - Investing.com UK
Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last? - Yahoo Finance
Barclays PLC Purchases 72,591 Shares of Liquidia Co. (NASDAQ:LQDA) - Defense World
Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 By Investing.com - Investing.com Australia
Rajeev Saggar Sells 6,249 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Roger Jeffs Sells 22,343 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Liquidia Co. (NASDAQ:LQDA) General Counsel Russell Schundler Sells 16,393 Shares - MarketBeat
Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock By Investing.com - Investing.com Australia
Liquidia's chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Australia
Liquidia’s chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Nigeria
Liquidia Corp chief business officer sells $56,650 in stock By Investing.com - Investing.com South Africa
Liquidia's chief commercial officer sells shares worth $98,504 - Investing.com India
Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock - Investing.com India
Liquidia Corp general counsel sells shares worth $193,109 - Investing.com India
Liquidia Corp chief business officer sells $56,650 in stock - Investing.com
Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 - Investing.com
Liquidia Corp general counsel sells shares worth $193,109 By Investing.com - Investing.com UK
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.
Liquidia’s (LQDA) Buy Rating Reiterated at Needham & Company LLC - Defense World
Analysts Set Liquidia Co. (NASDAQ:LQDA) Price Target at $25.38 - MarketBeat
Liquidia's (LQDA) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Breaking Down Liquidia: 4 Analysts Share Their Views - Benzinga
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Liquidia CEO to Present at J.P. Morgan Healthcare Conference 2025 in San Francisco - StockTitan
Yutrepia's Launch: A Catalyst for Liquidia (LQDA) - substack.com
Liquidia Co. (NASDAQ:LQDA) Shares Sold by Geode Capital Management LLC - MarketBeat
Barclays PLC Buys 72,591 Shares of Liquidia Co. (NASDAQ:LQDA) - MarketBeat
Barclays PLC Boosts Stock Position in Liquidia Co. (NASDAQ:LQDA) - Defense World
Jim Cramer’s Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know - Insider Monkey
State Street Corp Decreases Stock Holdings in Liquidia Co. (NASDAQ:LQDA) - Defense World
State Street Corp Has $21.75 Million Holdings in Liquidia Co. (NASDAQ:LQDA) - MarketBeat
Liquidia (NASDAQ:LQDA) Research Coverage Started at Wells Fargo & Company - Defense World
Wells Fargo & Company Initiates Coverage on Liquidia (NASDAQ:LQDA) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $833,000 Stake in Liquidia Co. (NASDAQ:LQDA) - Defense World
Liquidia Co. (NASDAQ:LQDA) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Analysts Set Liquidia Co. (NASDAQ:LQDA) Price Target at $24.00 - MarketBeat
Charles Schwab Investment Management Inc. Purchases 230,820 Shares of Liquidia Co. (NASDAQ:LQDA) - Defense World
Liquidia stock gains after win in patent dispute with United Therapeutics - Seeking Alpha
Here’s Arquitos Capital Management’s Updates on Liquidia (LQDA) - Yahoo Finance
Does Liquidia Technologies (LQDA) Have the Potential to Rally 132.54% as Wall Street Analysts Expect? - Yahoo Finance
Zurcher Kantonalbank Zurich Cantonalbank Has $187,000 Stake in Liquidia Co. (NASDAQ:LQDA) - Defense World
Finanzdaten der Liquidia Corp-Aktie (LQDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):